We are live on
!
Find out more
HTI
Hikari Tsushin Inc Portfolio holdings
AUM
$1.45B
1-Year Est. Return
3.37%
This Fund
S&P 500
This Quarter
Est. Return
-0.34%
1 Year Est. Return
+3.37%
3 Year Est. Return
+64.01%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$380M
AUM Growth
-$26.9M
(-6.6%)
Cap. Flow
-$24.8M
Cap. Flow
% of AUM
-6.52%
Top 10 Holdings %
Top 10 Hldgs %
82.65%
Holding
39
New
1
Increased
–
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$11.5M |
| 2 |
AB InBev
BUD
|
+$3.64M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$3.25M |
| 4 |
Walmart Inc
WMT
|
+$2.14M |
| 5 |
PX
Praxair Inc
PX
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 54.97% |
| 2 | Healthcare | 18.67% |
| 3 | Technology | 11.96% |
| 4 | Consumer Staples | 5.81% |
| 5 | Communication Services | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.07T
| $157M | 41.32% |
726
| – | – |
|
2
Wells Fargo
WFC
$261B
| $42.3M | 11.13% |
998,202
| – | – |
|
3
IBM
IBM
$202B
| $28.4M | 7.46% |
186,711
| – | – |
|
|
4
Coca-Cola
KO
$354B
| $15.7M | 4.13% |
370,973
-262,700
| -41% | -$11.5M |
|
5
Alphabet (Google) Class A
GOOGL
$3.91T
| $15.3M | 4.04% |
381,600
| – | – |
|
6
Cisco
CSCO
$450B
| $11.9M | 3.14% |
375,900
| – | – |
|
7
Johnson & Johnson
JNJ
$635B
| $11.7M | 3.09% |
99,360
| – | – |
|
|
NVO
8
Novo Nordisk
NVO
$216B
| $11.5M | 3.03% |
553,140
| – | – |
|
9
Medtronic
MDT
$107B
| $11.3M | 2.96% |
130,270
| – | – |
|
10
DaVita
DVA
$15.1B
| $8.9M | 2.34% |
134,730
| – | – |
|
11
Visa
V
$677B
| $8.4M | 2.21% |
101,598
| – | – |
|
12
Sanofi
SNY
$104B
| $6.27M | 1.65% |
164,230
| – | – |
|
13
Intuitive Surgical
ISRG
$121B
| $5.49M | 1.44% |
68,130
| – | – |
|
14
Danaher
DHR
$135B
| $4.69M | 1.23% |
67,494
-21,530
| -24% | -$1.53M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $4.56M | 1.2% |
19,800
| – | – |
|
16
3M
MMM
$89B
| $3.88M | 1.02% |
26,312
| – | – |
|
17
AbbVie
ABBV
$458B
| $3.76M | 0.99% |
59,550
| – | – |
|
|
PX
18
DELISTED
Praxair Inc
PX
| $3.46M | 0.91% |
28,600
-17,300
| -38% | -$2.05M |
|
19
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$293M
| $3.34M | 0.88% |
105,742
| – | – |
|
20
Abbott
ABT
$180B
| $2.78M | 0.73% |
65,750
| – | – |
|
21
iShares Biotechnology ETF
IBB
$9.31B
| $2.75M | 0.72% |
28,500
| – | – |
|
22
Procter & Gamble
PG
$343B
| $2.64M | 0.69% |
29,420
| – | – |
|
23
Kraft Heinz
KHC
$30.4B
| $2.59M | 0.68% |
28,972
| – | – |
|
24
Ecolab
ECL
$75.6B
| $1.98M | 0.52% |
16,296
| – | – |
|
25
Roper Technologies
ROP
$36.3B
| $1.82M | 0.48% |
10,000
| – | – |
|
Similar funds
DP
CHAM
SIM
AT
VIP
SIA
CIM
BFA
Hikari Tsushin Inc's Q3 2016 Portfolio in Review
As of Q3 2016, Hikari Tsushin Inc held 39 positions worth $380M, down 6.6% from $407M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Hikari Tsushin Inc withdrew a net $24.8M in Q3 2016, closing 5 positions and reducing 3 holdings. Its most notable exit was AB InBev, an estimated $3.64M position sold in full.
By sector, the portfolio is most concentrated in Financials at 55% of assets, up from 52% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Hikari Tsushin Inc opened a new position in Fortive worth $1.52M.
- Hikari Tsushin Inc's largest Q3 2016 buy was Fortive: 47,441 shares worth $1.52M.
- Hikari Tsushin Inc's biggest Q3 2016 reduction was Coca-Cola, cutting an estimated $11.5M.
- Hikari Tsushin Inc fully exited AB InBev in Q3 2016, selling an estimated $3.64M.
- Hikari Tsushin Inc's ten largest holdings make up 83% of its $380M portfolio in Q3 2016.
- Hikari Tsushin Inc opened 1 new position and closed 5 in Q3 2016.
- Hikari Tsushin Inc's portfolio value fell 6.6% quarter-over-quarter to $380M.
Based on Hikari Tsushin Inc's 13F filing for Q3 2016, filed 14 Nov 2016.